The FDA’s accelerated approval process had attracted criticism from researchers, FDA advisory committee members, and now congress. It was originally designed in 1992 to fast tract treatments for ...
The U.S. Food and Drug Administration’s (FDA) approval of the first-ever disease-slowing therapy for Alzheimer’s has given hope to millions of Americans, their families, and caregivers who are all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback